Mary Spellman
2018
In 2018, Mary Spellman earned a total compensation of $1.3M as Chief Medical Officer at VYNE Therapeutics, a 113% increase compared to previous year.
Compensation breakdown
| Bonus | $154,667 |
|---|---|
| Option Awards | $795,332 |
| Salary | $386,667 |
| Total | $1,336,666 |
Spellman received $795.3K in option awards, accounting for 60% of the total pay in 2018.
Spellman also received $154.7K in bonus and $386.7K in salary.
Rankings
In 2018, Mary Spellman's compensation ranked 7,735th out of 14,244 executives tracked by ExecPay. In other words, Spellman earned more than 45.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,735 out of 14,244 | 46th |
Division Manufacturing | 3,014 out of 5,765 | 48th |
Major group Chemicals And Allied Products | 1,128 out of 2,128 | 47th |
Industry group Drugs | 952 out of 1,817 | 48th |
Industry Pharmaceutical Preparations | 742 out of 1,391 | 47th |
Source: SEC filing on May 10, 2019.
Spellman's colleagues
We found two more compensation records of executives who worked with Mary Spellman at VYNE Therapeutics in 2018.